Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer-Reference-Cited by-全球学者库

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer

Published:2014-03-20 Issue:8 Volume:135 Page:1961-1969
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Hu Xichun¹,Zhang Jian¹,Xu Binghe²,Jiang Zefei³,Ragaz Joseph⁴,Tong Zhongsheng⁵,Zhang Qingyuan⁶,Wang Xiaojia⁷,Feng Jifeng⁸,Pang Danmei⁹,Fan Minhao¹,Li Jin¹,Wang Biyun¹,Wang Zhonghua¹,Zhang Qunling¹,Sun Si¹,Liao Chunmei¹

Affiliation:

1. Department of Medical Oncology; Fudan University, Shanghai Cancer Center, China; Department of Oncology; Shanghai Medical College, Fudan University; Shanghai China

2. Cancer Hospital, Chinese Academy of Medical Sciences; Beijing China

3. Department of Breast Cancer; Affiliated Hospital of Academy of Military Medical Sciences; Beijing China

4. School of Population and Public Health; University of British Columbia; Vancouver BC Canada

5. Tianjin Medical University Cancer Institute and Hospital; Tianjin China

6. Harbin Medical University Cancer Hospital; Harbin China

7. Zhejiang Cancer Hospital; Hangzhou China

8. Department of Medical Oncology; Nanjing Medical University affiliated Cancer Hospital; Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research; Nanjing China

9. Foshan No. 1 People's Hospital; Foshan China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Chemotherapy for metastatic breast cancer;Mayer;Hematol Oncol Clin North Am,2007

2. Molecular stratification of triple-negative breast cancers;Perou;Oncologist,2011

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

4. T1N0 triple negative breast cancer: risk of recurrence and adjuvant chemotherapy;Kaplan;Breast J,2009

5. Repeated observation of breast tumor subtypes in independent gene expression data sets;Sorlie;Proc Natl Acad Sci USA,2003

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer;BMC Cancer;2024-01-05

2. Development of a green, concise synthesis of nicotinamide derivatives catalysed by Novozym® 435 from Candida antarctica in sustainable continuous-flow microreactors;RSC Advances;2024

3. A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer;Journal of Advanced Research;2023-12

4. Phase II study of apatinib plus exemestane in estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer;Cancer Biology & Therapy;2023-10-13

5. Malignant gastrointestinal neuroectodermal tumor: a case report and literature review;Annals of Medicine & Surgery;2023-10-12